Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Drugs

Showing results (881-890 of 7,076) with videos related to

Pageof 708
Sort By:
Drugs|August 1, 1994
Optimum outpatient therapy of skin and skin structure infectionsD M Failla, G A Pankey
Drugs|August 1, 1994
Foscarnet. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with viral infectionsA J Wagstaff, H M Bryson
Drugs|August 1, 1994
Lacidipine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of hypertensionC R Lee, H M Bryson
Drugs|August 1, 1994
Roxithromycin. An update of its antimicrobial activity, pharmacokinetic properties and therapeutic useA Markham, D Faulds
Drugs|September 1, 1994
Ganciclovir. An update of its therapeutic use in cytomegalovirus infectionA Markham, D Faulds
Drugs|October 1, 1994
Dirithromycin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacyR N Brogden, D H Peters
Drugs|November 1, 1994
Multidrug-resistant Enterococcus faecium. An untreatable nosocomial pathogenR V Spera, B F Farber
Drugs|November 1, 1994
Drug therapy of mastalgia. What are the options?P A Holland, C A Gateley
Drugs|January 1, 1994
Postmenopausal hormone replacement therapy and cardiovascular risk reduction. A reviewS D Kafonek
Drugs|January 1, 1994
Efficacy and safety of fluvastatin in women with primary hypercholesterolaemiaT K Peters, E N Muratti, M Mehra
Pageof 708

Showing results (881-890 of 7,076) with videos related to

Sort By:
Pageof 708
Drugs|August 1, 1994
Optimum outpatient therapy of skin and skin structure infectionsD M Failla, G A Pankey
Drugs|August 1, 1994
Foscarnet. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with viral infectionsA J Wagstaff, H M Bryson
Drugs|August 1, 1994
Lacidipine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of hypertensionC R Lee, H M Bryson
Drugs|August 1, 1994
Roxithromycin. An update of its antimicrobial activity, pharmacokinetic properties and therapeutic useA Markham, D Faulds
Drugs|September 1, 1994
Ganciclovir. An update of its therapeutic use in cytomegalovirus infectionA Markham, D Faulds
Drugs|October 1, 1994
Dirithromycin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacyR N Brogden, D H Peters
Drugs|November 1, 1994
Multidrug-resistant Enterococcus faecium. An untreatable nosocomial pathogenR V Spera, B F Farber
Drugs|November 1, 1994
Drug therapy of mastalgia. What are the options?P A Holland, C A Gateley
Drugs|January 1, 1994
Postmenopausal hormone replacement therapy and cardiovascular risk reduction. A reviewS D Kafonek
Drugs|January 1, 1994
Efficacy and safety of fluvastatin in women with primary hypercholesterolaemiaT K Peters, E N Muratti, M Mehra
Pageof 708